Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)

HKG:2196 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	62,131	63,583	67,854	98,266	139,764	149,388
Market Cap Growth	7.09%	-6.30%	-30.95%	-29.69%	-6.44%	105.18%
Enterprise Value	97,974	96,610	98,300	124,479	165,708	175,428
Last Close Price	13.92	14.12	16.61	23.89	32.15	34.36
PE Ratio	19.81	21.57	25.82	23.30	24.08	34.34
PS Ratio	1.44	1.46	1.49	1.98	2.92	4.15
PB Ratio	0.95	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	2.56	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	169.93	894.58	-	-	-	-
P/OCF Ratio	12.56	13.35	18.04	20.61	28.92	48.76
EV/Sales Ratio	2.24	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	16.27	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	34.26	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	267.96	1359.25	-	-	-	-
Debt / Equity Ratio	0.60	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.52	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	106.30	539.31	-	-	-	-
Asset Turnover	0.35	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	3.01	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.72	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.97	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.20%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.43%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Capital (ROIC)	1.74%	1.98%	0.84%	2.70%	2.21%	2.50%
Return on Capital Employed (ROCE)	3.20%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	5.05%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.59%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	2.13%	2.41%	1.79%	1.99%	2.14%	1.49%
Payout Ratio	69.40%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	-0.04%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	2.09%	2.39%	-0.61%	0.25%	2.14%	1.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.